Mumbai (Maharashtra) [India], July 24 (ANI): Shares of Biocon Ltd fell by nearly 2 per cent on Friday morning after the biopharmaceutical major posted 28 per cent fall in its June quarter (Q1 FY21) net profit at Rs 149 crore.

The fall was due to higher research and development spend, lower profit share in biosimilars business and lower profitability in the research services segment. The company had posted a profit of Rs 206 crore in the year-ago period.

Also Read | 'ShareIt Lite, Bigo Lite, Helo Lite, VFY Lite': Lighter Versions of Banned Chinese Mobile Apps Removed from Google Play Store and Apple App Store.

However, revenue from operations of the company rose by 14 per cent at Rs 1,690 crore versus Rs 1,483 crore in Q1 FY20.

Biocon said the COVID-19 national lockdown resulted in a temporary suspension of operations in all divisions. Since restarting, the expansion of shift working and other protection measures for employees allowed the divisions to return to near-normal levels of operation and get client projects largely back on schedule.

Also Read | Pic of Leopard Peeking in Safari Car is Going Viral For Its Punny Caption: Trending Topics, Viral Videos and Funny Memes of The Day.

At 11 am, Biocon stock was trading 1.98 per cent lower at Rs 421.80 per unit. (ANI)

(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)